On this page
Godrej Consumer's Bangladesh unit returns to profit after four years on Goodknight surge
Our read
Bangladesh and Sri Lanka gains sustain, but Indonesia's drag keeps GCPL's international segment a mixed story through FY26.
For operators
Goodknight's traction proves the mosquito-repellent category can anchor a turnaround, so double down on distribution and marketing muscle behind that hero SKU in Bangladesh while stabilizing Indonesia.
Watch
Bangladesh taka exchange rate and import policy on insect-control inputs
Ask next
The report,
GCPL's Bangladesh business turned profitable in FY26 after four years, driven by Goodknight mosquito-repellent sales and category investment. Revenue rose ~40% to ₹191.4 crore. Sri Lanka grew; Indonesia declined but is recovering.
Reported figures
From the report. Source details below
| Lanka turnover ₹97.26 crore up | 15.2% |
|---|---|
| Lanka PAT ₹12.38 crore up | 33% |
| Indonesia turnover | ₹1,972.3 crore |
| Indonesia PAT ₹298.21 crore down | 14% |
Other figures
- PAT ₹5.86 crore
- FY25 loss ₹9.6 crore
Why it matters to operators
Sustained profitability across Bangladesh, Sri Lanka, and a recovering Indonesia strengthens the case for deeper South Asian consolidation or bolt-on acquisitions in household-insecticide adjacencies.
What to watch next
- Indonesia quarterly PAT trajectory — confirmation of recovery vs deepening decline
- Goodknight market share and seasonal demand (monsoon-linked mosquito activity)
- Consolidated international segment margin in next quarterly results
- Competitive response from local FMCG players in Bangladesh/Sri Lanka
Likely next moves
Our read of what comes next — analysis, not reported by the source.
- GCPL likely to raise Goodknight capacity and marketing spend across Bangladesh and Sri Lanka
- Portfolio rebalancing toward high-margin insecticide and personal-care categories in emerging markets
- Selective price hikes to defend margins against FX and input cost pressure
The source
First seen